Navigation Links
Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
Date:4/24/2012

FORT LAUDERDALE, Fla., April 24, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals, soon to be changed from Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today that it has contracted with an FDA-approved manufacturer to begin production of the first supplement in its New Life Naturals™ product line.

The new supplement – New Life Naturals: For Her Senses™ – is an all-natural product intended to help the nearly 48% of American women suffering with female sexual dysfunction (FSD). Nouveau Life Pharmaceuticals began work on the supplement's formulation in February of this year and finalized the formula ahead of schedule. 

In order to minimize time-to-market and begin production immediately, Nouveau Life opted to partner with an FDA-approved manufacturing facility based in the U.S. The facility is a cGMP (current good manufacturing practice) compliant facility and meets all FDA requirements to manufacture food supplements and over the counter pharmaceuticals.

Nouveau Life expects production of the For Her Senses™ supplement to begin in the coming days and anticipates the nutraceutical will be available for sale to the public within two weeks.

About Hybrid Fuels, Inc.
The company was incorporated in the state of Nevada in 1998 as Polo Equities.  It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies. 

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.

CONTACT:

Nouveau Life Pharmaceuticals, Inc. - 954-903-2993


'/>"/>
SOURCE Nouveau Life Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Clinical Development Plans for ISIS-APOCIIIRx
4. Research Alert -- Empire Asset Management Co. Initiates Coverage on Pacira Pharmaceuticals Inc. (NASDAQ: PCRX)
5. Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
6. Valeant Pharmaceuticals to Announce 2012 First Quarter Results on May 3, 2012
7. Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®
8. Duane Morris Litigators Vincent Capuano, Anthony Fitzpatrick and Laura Vogel to Speak at American Conference Institutes Conference on Generic Pharmaceuticals
9. Qualitest Pharmaceuticals Receives FDA Approval for Levetiracetam Oral Solution, 100 mg/mL
10. MAP Pharmaceuticals Provides Update on LEVADEX® Program
11. Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2020)... ... ... Returning for a 3rd year, one of the most influential voices in ... on Friday, May 29th, at the Cannabis World Congress & Business Exposition ... York, taking place May 28–30, 2020 at the Jacob K. Javits Convention Center in ...
(Date:2/28/2020)... ... 27, 2020 , ... ProMach , a worldwide leader ... the company’s new Senior Vice President for its Pharma Business Line. Reporting to ... and commercial activity for ProMach’s Pharma product brands including NJM and WLS. , ...
(Date:2/28/2020)... BALTIMORE (PRWEB) , ... February 27, 2020 , ... At ... providers anywhere using their phones, computers or tablets with the VA Video Connect application. ... get the care they need via secure, live video telehealth appointments. The VA Video ...
Breaking Medicine Technology:
(Date:2/26/2020)... (PRWEB) , ... February 26, 2020 , ... ... 2020 at 1pm EST with featured speaker Cristian Ionescu-Zanetti, PhD, Chief Technology Officer, ... , The IsoFlux system is a bench-top solution for high-sensitivity circulating tumor cell ...
(Date:2/23/2020)... ... February 22, 2020 , ... One of the stars of ... is the host of the informational program “Behind The Scenes.” “Behind The Scenes” ... the country. A soon to be aired episode will interview industry professionals about ...
(Date:2/21/2020)... MIAMI LAKES, Fla. (PRWEB) , ... February 21, ... ... today announced that it is now offering a 10 percent grand opening ... and get 10 percent off all purchases," said Osmay Gonzalez, spokesperson for Baby ...
(Date:2/21/2020)... ... February 21, 2020 , ... Cosmetic surgery continues ... Society of Plastic Surgeons (ASPS). According to the ASPS, there were 17.7-million cosmetic ... over the previous year. The American Society of Plastic Surgeons reported that some ...
(Date:2/20/2020)... ... 2020 , ... R3 Medical Training announced its next joint injection training courses ... perform injections for all large and small joints along with ultrasound needle guidance. , ... best opportunity is to perform injections in a supervised setting. R3 Medical Training's ...
Breaking Medicine News(10 mins):